Beijing Biostar Pharmaceuticals Co., Ltd. (SEHK: 2563)
Health Care · Biotechnology · CN
HK$4.30
-10.97% today · -41.1% 1Y
Beijing Biostar Pharmaceuticals Co., Ltd. (SEHK: 2563) operates in the Biotechnology industry within the Health Care sector. The company is valued at $213.47M and employs 134 people.
Over the last twelve months the share price has lost 41.1%, trading between 2.40 and 7.98.
Tweenvest scores Beijing Biostar Pharmaceuticals Co., Ltd. across four factors: quality 42/100, value 84/100. Its strongest factor is value.
2563 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $213.47M
- Revenue (TTM)
- $8.13M
- P/E
- —
- EPS
- -0.29
- Dividend yield
- —
- Beta (5Y)
- -0.51
- 52-week high
- HK$7.98
- 52-week low
- HK$2.40
- Avg volume (3M)
- —
- Shares outstanding
- 389.59M
- Employees
- 134
- Next earnings
- —
About Beijing Biostar Pharmaceuticals Co., Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. primarily focuses on developing innovative therapies for tumors. The company is dedicated to creating novel anti-cancer drugs, each secured by independent intellectual property rights. A prominent product in its portfolio is the Utidelone injection, a next-generation microtubule inhibitor produced through a unique microbial fermentation process. This enterprise was co-founded by Li Tang and Rong Guo Qiu on July 11, 2002, and operates from its headquarters in Beijing, China.
- ISIN
- CNE100006NB3
- Founded
- 2002
- Listed since
- Oct 31, 2024
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| ADC Therapeutics SANYSE: ADCT | $220.87M | $1.73 | 0.00% |
| HansBiomed CorporationKOSDAQ: A042520 | $219.06M | ₩20,650.00 | -2.82% |
| Panacea Biotec LimitedNSEI: PANACEABIO | $218.50M | Rs345.25 | -3.84% |
| Transgene SAENXTPA: TNG | $214.67M | €0.70 | 0.00% |
| Cartesian Therapeutics, Inc.NasdaqGM: RNAC | $213.45M | $7.06 | -4.14% |
| Lyell Immunopharma, Inc.NasdaqGS: LYEL | $213.44M | $8.71 | -5.94% |
| Genome & CompanyKOSDAQ: A314130 | $212.80M | ₩5,470.00 | -0.55% |
| Invivyd, Inc.NasdaqGM: IVVD | $212.58M | $0.74 | +2.61% |
Figures last refreshed Oct 11, 2026.